Adverse Drug Reaction vs Care Complication: Response to "Use of Colony-Stimulating Factors in Patients With Systemic Lupus Erythematous"

J Pharm Pract. 2024 Apr;37(2):259-260. doi: 10.1177/08971900221149549. Epub 2023 Jan 2.

Authors

Carolyn E Ragsdale¹, Edwin P Rock¹

Affiliation

¹ Partner Therapeutics, Inc., Lexington, MA, USA.

PMID: 36592453
DOI: 10.1177/08971900221149549

No abstract available

Publication types

Letter
Comment

MeSH terms

Colony-Stimulating Factors
Drug-Related Side Effects and Adverse Reactions*
Erythema
Humans
Lupus Erythematosus, Systemic* / complications
Lupus Erythematosus, Systemic* / drug therapy
Patients

Substances

Colony-Stimulating Factors